Advances in follicular lymphoma.
Follicular lymphoma is a usually indolent lymphoma that responds well to chemotherapy. While multiple treatments show a good response rate, most patients relapse. Emerging therapies, such as antibody therapy and stem cell transplantation, are increasingly being used to try to lengthen response time. This article will review the available treatments for follicular lymphoma and discuss the studies supporting newer strategies of treatment.
Archuleta
Travis D
TD
Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198-7860, USA.
Armitage
James O
JO
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D008224:Lymphoma, Follicular / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D033581:Stem Cell Transplantation
D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines; D018796:Immunoconjugates; D016376:Oligonucleotides, Antisense; D011480:Protease Inhibitors; D007372:Interferons